Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent
1991-03-20
1993-11-02
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
514152, A61K 3165
Patent
active
052583724
ABSTRACT:
Methods and products for overcoming bacterial resistance to tetracycline-type antibiotics by inhibiting the plasmid-mediated active efflux system for tetracycline in the resistant bacterial cell by administering with tetracycline efflux system blocking agents of doxycycline or sancycline, thereby increasing the sensitivity of the resistant cell to tetracycline type antibiotics.
REFERENCES:
patent: 3454697 (1969-07-01), Joyner et al.
patent: 4024272 (1977-05-01), Rogalaski et al.
patent: 4126680 (1978-11-01), Armstrong
patent: 4806529 (1989-02-01), Levy
Grassi et al., New Trends in Antibodies: Research and Therapy, pp. 3-54 (1981).
CA: 89: 71494n (Connamacher et al.) (1978).
CA: 90: 198211u (Samra et al.) (1979).
CA: 83: 1393f (Candanoza et al.) (1975).
CA: 81: 115200e (Leigh et al.) (1974).
CA: 82: 26560a (Lebek et al.) (1975).
CA: 74: 74941g (Kuck et al.) (1971).
Conlin David G.
Criares T. J.
Trustees of Tufts College
Waddell Frederick E.
Williams Gregory D.
LandOfFree
Tetracycline activity enhancement using doxycycline or sancyclin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetracycline activity enhancement using doxycycline or sancyclin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetracycline activity enhancement using doxycycline or sancyclin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1757556